UBS Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Sell |
|
|||||
|
2025
Q1 | $8.2M | Buy |
|
|||||
|
2024
Q4 | $7.23M | Buy |
|
|||||
|
2024
Q3 | $3.39M | Buy |
|
|||||
|
2024
Q2 | $2.14M | Buy |
|
|||||
|
2024
Q1 | $2.2M | Sell |
|
|||||
|
2023
Q4 | $1.89M | Buy |
|
|||||
|
2023
Q3 | $525K | Sell |
|
|||||
|
2023
Q2 | $1.62M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Buy |
|
|||||
|
2022
Q4 | $1M | Buy |
|
|||||
|
2022
Q3 | $256K | Buy |
|
|||||
|
2022
Q2 | $45K | Sell |
|
|||||
|
2022
Q1 | $2.71M | Sell |
|
|||||
|
2021
Q4 | $2.89M | Buy |
|
|||||
|
2021
Q3 | $81K | Sell |
|
|||||
|
2021
Q2 | $744K | Sell |
|
|||||
|
2021
Q1 | $4.58M | Sell |
|
|||||
|
2020
Q4 | $4.56M | Buy |
|
|||||
|
2020
Q3 | $350K | Sell |
|
|||||
|
2020
Q2 | $706K | Sell |
|
|||||
|
2020
Q1 | $734K | Sell |
|
|||||
|
2019
Q4 | $1.27M | Buy |
|
|||||
|
2019
Q3 | $4.49M | Sell |
|
|||||
|
2019
Q2 | $23M | Buy |
|
|||||
|
2019
Q1 | $23.7M | Buy |
|
|||||
|
2018
Q4 | $11.7M | Buy |
|
|||||
|
2018
Q3 | $16.3M | Buy |
|
|||||
|
2018
Q2 | $1.77M | Buy |
|
|||||
|
2018
Q1 | $657K | Buy |
|
|||||
|
2017
Q4 | $546K | Sell |
|
|||||
|
2017
Q3 | $1.78M | Buy |
|
|||||
|
2017
Q2 | $637K | Sell |
|
|||||
|
2017
Q1 | $468K | Sell |
|
|||||
|
2016
Q4 | $505K | Sell |
|
|||||
|
2016
Q3 | $684K | Buy |
|
|||||
|
2016
Q2 | $92K | Buy |
|
|||||
|
2016
Q1 | $68K | Sell |
|
|||||
|
2015
Q4 | $698K | Buy |
|
|||||
|
2015
Q3 | $705K | Buy |
|
|||||
|
2015
Q2 | $798K | Buy |
|
|||||
|
2015
Q1 | $540K | Buy |
|
|||||
|
2014
Q4 | $269K | Buy |
|